Risk stratification of emergency department patients with acute coronary syndromes using P-selectin

Journal of the American College of Cardiology

Volumn 34, Issue 1, 1999, Pages 95-105

  Hollander, Judd E ^a   Muttreja, M Ranu ^a   Dalesandro, Margaret R ^b   Shofer, Frances S ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; PADGEM PROTEIN;

ADULT; AGED; ARTICLE; EARLY DIAGNOSIS; EMERGENCY TREATMENT; ENZYME ASSAY; FEMALE; FLOW CYTOMETRY; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE AGGREGATION;

ADULT; AGED; CORONARY DISEASE; CREATINE KINASE; ELECTROENCEPHALOGRAPHY; EMERGENCIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; P-SELECTIN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0033165753     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00175-8     Document Type: Article

References (55)

1. Selker H.P. Coronary care unit triage decision aids how do we know when they work? Am J Med. 87:1989;491-492.
2. Tatum J.L., Jesse R.L., Kontos M.C., et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med. 29:1997;116-125.
3. Baxt W.G. Use of an artificial neural network for the diagnosis of myocardial infarction. Ann Emerg Med. 115:1991;843-848.
4. Lee T.H., Cook E.F., Weisberg M., et al. Acute chest pain in the emergency department. Arch Intern Med. 145:1985;65-69.
5. Lee T.H., Juarez G., Cook E.F., et al. Ruling out acute myocardial infarction. A prospective multicenter validation of a 12 hour strategy for patients at low risk. N Engl J Med. 324:1991;1239-1246.
6. Goldman L., Weinberg M., Weisberg M., et al. A computer derived protocol to aid in the diagnosis of emergency room patients with acute chest pain. N Engl J Med. 307:1982;588-596.
7. Pozen M.W., D'Agostino R.B., Selker H.P., et al. A predictive instrument to improve coronary care unit admission practices in ischemic heart disease. A prospective multicenter clinical trial. N Engl J Med. 310:1984;1273-1278.
8. Goldman L., Cook E.F., Brand D.A., et al. A computer derived protocol to predict myocardial infarction in emergency department patients with chest pain. N Engl J Med. 318:1988;797-803.
9. Fesmire F.M., Smith E.E. Continuous 12 lead electrocardiograph monitoring in the emergency department. Am J Emerg Med. 11:1993;54-60.
10. Gibler W.B., Sayre M.R., Levy R.C., et al. Serial 12 lead electrocardiographic monitoring in patients presenting to the emergency department with chest pain. J Electrocardiol. 26S:1994;238-243.
11. Zalenski R.J., Cooke D., Rydman R., et al. Assessing the diagnostic value of an ECG containing leads V4R, V8, and V9 the 15 lead ECG . Ann Emerg Med. 22:1993;786-793.
12. Candell-Riera J., Figueras J., Vaile V., et al. Right ventricular infarction relationships between ST segment elevation in V4R and hemodynamic, scintigraphic, and echocardiographic findings in patients with acute inferior myocardial infarction . Am Heart J. 101:1981;281-287.
13. Justis D.L., Hession W.T. Accuracy of 22 lead ECG analysis for diagnosis of acute myocardial infarction and coronary artery disease in the emergency department a comparison with 12 lead ECG . Ann Emerg Med. 21:1992;1-9.
14. Gibler W.B., Lewis L.M., Erb R.E., et al. Early detection of acute myocardial infarction in patients presenting with chest pain and nondiagnostic ECGs serial CK-MB sampling in the emergency department . Ann Emerg Med. 19:1990;1359-1366.
15. Green G.B., Hansen K.N., Chan D.W., et al. The potential utility of a rapid CK-MB assay in evaluating emergency department patients with possible myocardial infarction. Ann Emerg Med. 20:1991;954-960.
16. Hedges J.R., Rouan G.W., Toltzis R., et al. Use of cardiac enzymes identifies patients with acute myocardial infarction otherwise unrecognized in the emergency department. Ann Emerg Med. 16:1987;248-252.
17. Gibler W.B., Young G.P., Hedges J.R., et al. Acute myocardial infarction in chest pain patients with non diagnostic ECGs serial CK-MB sampling in the emergency department . Ann Emerg Med. 21:1992;504-512.
18. Hoekstra J.W., Hedges J.R., Gibler W.B., et al. Emergency department CK-MB a predictor of ischemic complications . Acad Emerg Med. 1:1994;17-28.
19. Hedges J.R., Young G.P., Henkel G.F., et al. Early CK-MB elevations predict ischemic events in stable chest pain patients. Acad Emerg Med. 1:1994;9-16.
20. Lee T.H., Weisberg M.C., Cook E.R., et al. Evaluation of creatine kinase and creatine kinase-MB for diagnosing myocardial infarction clinical impact in the emergency room . Arch Intern Med. 147:1987;115-121.
21. Brogan G.X. Jr, Friedman S., McCuskey C., et al. Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CK-MB for ruling out acute myocardial infarction in the emergency department. Ann Emerg Med. 24:1994;665-671.
22. Mair J., Artner-Dworzak E., Lechleitner P., et al. Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin. Br Heart J. 68:1992;462-468.
23. Gibler W.B., Gibler C.D., Weinshenker E., et al. Myoglobin as an early indicator of acute myocardial infarction. Ann Emerg Med. 16:1987;851-856.
24. Davis C.P., Barrett K., Torre P., Wacasey K. Serial myoglobin levels for patients with possible myocardial infarction. Acad Emerg Med. 3:1996;590-597.
25. Tucker J.F., Collins R.A., Anderson A.J., et al. Value of serial myoglobin levels in the early diagnosis of patients admitted for acute myocardial infarction. Ann Emerg Med. 24:1994;704-708.
26. Brogan G.X., Hollander J.E., McCuskey C.F., et al. Evaluation of a new assay for cardiac troponin I versus CK-MB for the diagnosis of acute myocardial infarction. Acad Emerg Med. 4:1997;6-12.
27. Antman E.M., Tanasijevic M.J., Thompson B., et al. Cardiac specific troponin I levels predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 335:1996;1342-1349.
28. Ohman E.M., Armstrong P.W., Christenson R.H., et al. Cardiac troponin-T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 335:1996;1333-1341.
29. Antman E.M., Grudzien C., Sacks D.B. Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. JAMA. 273:1995;1279-1282.
30. Hamm C.W., Goldmann B.U., Heeschen C., et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or I. N Engl J Med. 337:1997;1648-1653.
31. Hoekstra J.W., Gibler W.B., Levy R.C., et al. Emergency department diagnosis of acute myocardial infarction and ischemia a cost analysis of two diagnostic protocols . Acad Emerg Med. 1:1994;103-110.
32. Gibler W.B., Runyon J.P., Levy R.C., et al. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med. 25:1995;1-8.
33. Gaspoz J.M., Lee T.H., Cook E.F., et al. Outcome of patients who were admitted to a new short stay unit to rule out myocardial infarction. Am J Cardiol. 68:1991;145-149.
34. Roberts R.R., Zalenski R.J., Mensah E.K., et al. Cost of an emergency department-based accelerated diagnostic protocol vs. hospitalization in patients with chest pain. A randomized controlled trial. JAMA. 278:1997;1670-1676.
35. Ikeda H., Takajo Y., Ichiki K., et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation. 92:1995;1693-1696.
36. Ikeda H., Nakayam H., Oda T., et al. Soluble form of P-selectin in patients with acute myocardial infarction. Coron Artery Dis. 5:1994;515-518.
37. Sakamaki F., Ishizaka A., Handa M., et al. Soluble form of P selectin in plasma is elevated in acute lung injury. Am J Respir Crit Care Med. 151:1995;1821-1826.
38. Ushiyama S., Laue T.M., Moore K.L., et al. Structural and functional characterization of monomeric soluble P selectin and comparison with membrane P selectin. J Biol Chem. 268:1993;15229-15237.
39. Nurden A.T., Macchi L., Bihour C., et al. Markers of platelet activation in coronary heart disease patients. Eur J Clin Invest. 24:(Suppl 1):1994;42-45.
40. Hollander J.E., Lozano M. Jr, Goldstein E., et al. Variations in the electrocardiograms of young adults are revised criteria for thrombolysis necessary? Acad Emerg Med. 1:1994;94-102.
41. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., et al. Myocardial infarction and coronary deaths in the World Health Organization Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 90:1994;583-612.
42. Braunwald E., Mark D.B., Jones R.H., et al. Unstable Angina: Diagnosis and Management. Clinical Practice Guideline Number 10 (amended), AHCPR Publication No. 94-0602. 1994;Agency for Health Care Policy and Research and the National Health, Lung and Blood Institute, Public Health Service, U.S. Department of Health and Human Services, Rockville (MD).
43. Fleiss J.L. Statistical Methods for Rates and Proportions. 2nd ed. 1981;14 Wiley, New York.
44. DeWood M.A., Spores J., Notske R., et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 303:1980;897-902.
45. Ambrose J.A., Weintrauch M. Thrombosis in ischemic heart disease. Arch Intern Med. 156:1996;1382-1394.
46. Coller B.S. Blockade of platelet GP IIb/IIIa receptors as an antithrombotic strategy. Circulation. 92:1995;2373-2380.
47. McEver R.P., Beckstead J.H., More K.L., et al. GMP-40, a platelet alpha granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest. 84:1989;92-99.
48. Berman C.L., Yeo E.L., Wencel-Drake J.D., et al. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. J Clin Invest. 78:1986;130-137.
49. Fijnheer R., Frijns C.J.M., Korteweg J., et al. The origin of P selectin as a circulating plasma protein. Thromb Haemost. 77:1997;1081-1085.
50. Katayama M., Handa M., Araki Y., et al. Soluble P selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Br J Haematol. 84:1993;702-710.
51. Bellon J.L., Castellanos C., Acevedo L., Amiral J. Measurement of beta-thromboglobulin and platelet factor 4 to follow up patients with artificial heart valves. Semin Thromb Hemost. 19:(Suppl 1):1993;178-182.
52. Neumann F.J., Gawaz M., Dickfield T., et al. Antiplatelet effect of ticlopidine after coronary stenting. J Am Coll Cardiol. 29:1997;1515-1519.
53. Kawano K., Aoki I., Aoki N., et al. Human platelet activation by thrombolytic agents effects of tissue type plasminogen activator and urokinase on platelet surface P-selectin expression . Am Heart J. 135:1998;268-271.
54. Shimomura H., Ogawa H., Arai H., et al. Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction. Am J Cardiol. 81:1998;397-400.
55. Cannon CP, Ault K, Mitchell J, et al. P-selectin in patients post acute coronary syndromes treated with Sibrafiban, an oral IIb/IIIa antagonist: results from TIMI 12. Circulation 1997;96 Suppl 932:I-169.